viDA Therapeutics Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Series A
  • Latest Deal Amount
  • $15M
Latest Deal Amount
  • Investors
  • 3

viDA Therapeutics General Information


Operator of a biopharmaceutical company intended to assist in the treatment of age-related chronic inflammatory diseases. The company's services include the research and development of therapeutics targeting granzyme serine proteases that eliminate diseases such as inflammation, disruption of barrier function and vascular leakage, enabling the healthcare industry to improve the overall medical treatment offered to the patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 333 Roche Point Drive
  • Vancouver, British Columbia V7G 2G4
  • Canada
+1 (604) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

viDA Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC (Series A) $15M 000.00 Completed Pre-Clinical Trials
3. Later Stage VC 10-Jul-2013 00.000 00.000 Completed Pre-Clinical Trials
2. Seed Round 24-Apr-2013 $3.65M $3.65M Completed Startup
1. Grant 20-Apr-2010 $68K Completed Startup
To view viDA Therapeutics’s complete valuation and funding history, request access »

viDA Therapeutics Executive Team (7)

Name Title Board Seat Contact Info
Alistair Duncan Co-Founder, President, Chief Executive Officer & Board Member
David Granville Ph.D Co-Founder & Chief Scientific Officer
Vicki Morgan Vice President of Business Development
Jeff Charpentier Advisor, Financial
You’re viewing 4 of 7 executive team members. Get the full list »

viDA Therapeutics Board Members (9)

Name Representing Role Since
Alistair Duncan viDA Therapeutics Co-Founder, President, Chief Executive Officer & Board Member 000 0000
Charles Cazabon Business Development Bank of Canada Board Member 000 0000
Dominique Bélanger BDC Capital Board Member 000 0000
Don Campbell viDA Therapeutics Chairman 000 0000
Gosse Bruinsma MD Self Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

viDA Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

viDA Therapeutics Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Discovery Parks Fund of Funds Minority 000 0000 000000 0
BDC Capital Venture Capital Minority 000 0000 000000 0
Carmanah Venture Capital Minority 000 0000 000000 0
To view viDA Therapeutics’s complete investors history, request access »